The role of macrophages in right ventricular remodeling in experimental pulmonary hypertension

Sue Gu1,2, Claudia Mickael1,3, Rahul Kumar4

  • 1Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine University of Colorado Anschutz Medical Campus Aurora Colorado USA.

Pulmonary Circulation
|July 25, 2022
PubMed

Insights

Macrophages in the right ventricle (RV) increase during pulmonary hypertension (PH). These macrophages influence RV remodeling by altering the extracellular matrix, contributing to RV failure.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Pulmonary Hypertension Research

Background:

  • Right ventricular (RV) failure is a major cause of mortality in pulmonary hypertension (PH).
  • The precise mechanisms driving RV failure in PH remain incompletely understood.
  • Macrophages are increasingly recognized as key players in cardiovascular disease pathogenesis.

Purpose of the Study:

  • To investigate the role of cardiac macrophages in the RV response to pulmonary hypertension.
  • To determine if macrophage subpopulations in the RV change during PH.
  • To elucidate the impact of macrophage depletion on RV remodeling and function in experimental PH.

Main Methods:

  • Induction of pulmonary hypertension in mice (hypoxia, Schistosoma mansoni) and rats (SU5416-hypoxia).
  • Quantification of cardiac macrophages using flow cytometry and parabiosis models.
  • Macrophage depletion in rats using clodronate liposomes.
  • Assessment of RV extracellular matrix, vasculature, and function.

Main Results:

  • While overall macrophage numbers didn't change in hypoxia-exposed mice, specific subpopulations increased.
  • Parabiosis revealed circulating-derived RV macrophages, with one subpopulation significantly expanding under PH stimuli.
  • Macrophage depletion in SU-Hx rats altered RV extracellular matrix composition without affecting vasculature, correlating with improved RV function.

Conclusions:

  • RV macrophage populations expand and contribute to RV remodeling in pulmonary hypertension.
  • These macrophages play a role in regulating the RV extracellular matrix.
  • Targeting RV macrophages may offer a therapeutic strategy for pulmonary hypertension-associated RV failure.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
277
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
49